Suggestions
Sagit Weiss
A senior global pharma executive (CNS and others). Clinical and medical affairs. Advisory boards. Fundraising
Professional Background
Sagit Weiss, MD, MSc, stands as a distinguished figure in the pharmaceutical industry with a wealth of experience in medical and clinical affairs, particularly in the domains of Multiple Sclerosis (MS) and Parkinson's Disease (PD). With a robust career dedicated to enhancing patient outcomes, Sagit has consistently demonstrated exceptional problem-solving skills within medical and clinical environments, focusing on innovative approaches to patient care and public engagement in medical research.
Sagit’s career highlights numerous prestigious roles, each marking significant contributions to the medical field. As a former Medical Director at Handl Therapeutics, Sagit utilized her extensive knowledge to guide medical strategies and oversee pivotal clinical projects. Her experience as a Clinical Fellow at the NHS allowed her to deepen her insights into the healthcare system and patient needs, further informing her approach to pharmaceutical development.
Furthermore, her tenure as Director of Clinical Research for Phase II trials, co-sponsored by the NIH at Santhera Pharmaceuticals, showcased her ability to lead complex clinical studies while collaborating with reputable institutions. Sagit is also the founder and CEO of Crowdacure, where she championed initiatives aimed at boosting awareness and engagement in medical research, thereby bridging the gap between researchers and the community.
Education and Achievements
Sagit Weiss's educational foundation is profound and lays the groundwork for her esteemed career. She earned her Doctor of Medicine at Université Libre De Bruxelles, demonstrating her commitment to medical excellence early on. Following this, she pursued a Master’s in Immunology at the same esteemed institution, allowing her to hone her expertise in a critical field that informs many aspects of her work in MS and PD.
Her academic pursuits provided her with a deep understanding of the immune system's role in diseases, equipping her with the knowledge essential for her successful leadership in medical affairs. This educational background has not only contributed to her professional success but has also positioned her as a thought leader in her field, influencing both her peers and the next generation of medical professionals.
Notable Achievements
Throughout her dynamic career, Sagit has achieved numerous accolades and contributions that elevate her profile in the pharmaceutical landscape. As the Global Medical Director for Multiple Sclerosis at Teva Pharmaceuticals, she played a crucial role in advancing treatments and improving the lives of patients battling this challenging condition. Her ability to integrate scientific knowledge with real-world impacts has made her a sought-after expert in her areas of focus.
While serving as Medical Director at Brainsgate and as a medical advisor at Pfizer, Sagit's strategic acumen in clinical research has led to significant advancements in therapeutic approaches for neurological disorders. In her role as a medical manager at Sanofi-Aventis, she further exemplified her leadership in orchestrating medical strategies that align with patient needs.
Additionally, her research fellowship at the University of Rome "Tor Vergata" in the MS Unit allowed her to explore intricate subjects such as disability progression and synaptic plasticity. This work not only enriched her knowledge but also contributed to the evolving understanding of MS, reinforcing her status as a key contributor to the field.
Sagit Weiss, MD, MSc, embodies a holistic approach to medicine that prioritizes patient-centricity and leverages her extensive background to make meaningful advancements in the pharmaceutical industry. Her commitment to public engagement in medical research underscores her dedication to fostering a better understanding of diseases, enhancing patient outcomes, and ultimately transforming the healthcare landscape. Through her robust experience, Sagit continues to be an inspiration and leader in the fields of Multiple Sclerosis and Parkinson’s Disease.
